Shifting trends in colorectal cancer cases: More younger adults diagnosed

When it comes to colorectal cancer, there is good news and not-so-good news.

First the good news. Overall, the rate of people diagnosed with colon or rectal cancer, and the mortality rate for those diagnosed, has been declining for the past several decades. This decline is particularly found in those over age 50, and research shows* that the increase in colorectal cancer screenings among older adults has contributed to this decline.

The not-so-good news, however, is that colorectal cancer cases have been rising among adults younger than age 50. In fact, from 2012 to 2021, rates among younger adults have risen by 2.4% per year. According to the American Cancer Society,* in 1995, just 11% of colorectal cancers were in people aged 54 or younger. In 2019, that number was 20%.

Shifting trends mean a change in recommendations

The increase in younger adults with colon cancer has influenced a change in cancer screening recommendations. A few years ago, the U.S. Preventive Services Task Force lowered the recommended age to begin yearly colorectal cancer screenings to 45 from 50. This is the suggested age for those with an average risk of cancer.

Trends in racial and ethnic groups

There are some disparities* in colorectal cancer incidence and mortality among certain racial and ethnic groups.

• Incidence of colorectal cancer is highest among American Indian and Alaska Native individuals.
• Black Americans are 15% more likely than White Americans to get colorectal cancer and 35% more likely to die from it.
• Nearly 1 in 4 colorectal cancer cases in Black Americans are diagnosed at stages when it’s harder to treat.

In general, colorectal cancer has a survival rate of greater than 90% when found and treated early, which is why it’s so important to get regular screenings.

A resource for health care providers

Blue Cross Blue Shield of Michigan has developed a Star Measure tip sheet, Colorectal Cancer Screening (COL-E), that includes helpful hints such as:

• Discuss the benefits and risks of different screening options and make a plan that offers the best health outcomes for your patient.
• For patients who refuse a colonoscopy, discuss options of noninvasive screenings such as Cologuard^® or FIT.

*Blue Cross Blue Shield of Michigan doesn’t own or control this website.

Blue Cross Blue Shield of Michigan and Blue Care Network are nonprofit corporations and independent licensees of the Blue Cross and Blue Shield Association.